Prolocor Inc | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Prolocor Inc

BRIEF

published on 10/21/2024 at 17:05, 30 days 17 hours ago

Prolocor Unveils Results of Multicenter Study on Cardiovascular Risk in JACC

Prolocor PFCG® Test Cardiovascular Risk Antithrombotic Treatment JACC Publication Individualized Therapy
PRESS RELEASE

published on 10/21/2024 at 17:00, 30 days 17 hours ago

Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
Prolocor, Inc. announces publication of results from a confirmatory 800 patient ACS trial in JACC, showing a >2-fold predictive value for heart attack, stroke, and death. The Prolocor pFCG® test supports individualized antiplatelet therapy

Prolocor Inc. JACC Publication ACS Trial PFCG Test Antiplatelet Therapy
BRIEF

published on 09/05/2024 at 14:05, 2 months 15 days ago

Prolocor and Slingshot Biosciences Announce Publication in Bioanalysis

Prolocor PFCG® Test Thrombosis Prognosis TruCytes Cell Mimics Heart Attack Risk Precision Diagnostics
PRESS RELEASE

published on 09/05/2024 at 14:00, 2 months 15 days ago

Prolocor and Slingshot Biosciences Announce Publication of 'Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets' in Bioanalysis
Study in Bioanalysis shows Prolocor pFCG® test as reliable tool for thrombosis risk assessment with TruCytes cell mimics, accurate and precise. Partnership between Prolocor Inc. and Slingshot Biosciences

Partnership Prolocor PFCG® Test TruCytes Cell Mimics Thrombosis Risk Bioanalysis Study
BRIEF

published on 02/27/2024 at 15:00, 8 months 22 days ago

Prolocor raises $1.7 million for an accurate thrombosis risk diagnostic program

Funding Prolocor Thrombosis Medical Innovation Diagnostic
PRESS RELEASE

published on 02/27/2024 at 15:00, 8 months 22 days ago

Prolocor Announces $1.7 Million in Bridge Funding
Prolocor, Inc. raises $1.7 million in bridge financing to advance precision diagnostic test for predicting thrombosis risk. Funding from GPG Ventures and Labcorp Venture Fund

Bridge Financing Prolocor Inc. Precision Diagnostic Test Thrombosis Risk Prediction GPG Ventures
BRIEF

published on 02/20/2024 at 15:00, 9 months ago

Prolocor, Inc. Introduces a Breakthrough in Thrombosis Risk Diagnosis

Prolocor Thrombosis Precision Diagnosis Cardiology Medical Innovation
PRESS RELEASE

published on 02/20/2024 at 15:00, 9 months ago

Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCɣRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)
Prolocor, Inc. announces acceptance of abstract on platelet FcγRIIa implications in myocardial infarction treatment strategy at ACC Scientific Sessions 2024

Prolocor Inc. Platelet FcγRIIa Myocardial Infarction Treatment Strategy Clinical Program

Accesswire

Published on 11/21/2024 at 10:03, 52 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 55 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 55 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 20 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 30 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 25 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 50 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 53 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 55 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 55 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 57 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 35 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 10 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 10 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE